Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Aptamer
72%
Lymphoma Cells
29%
Acute Myeloid Leukemia
27%
Rituximab-CHOP
27%
Lymphoma
27%
Myeloma Cells
24%
Nucleic Acid Aptamer
23%
T Cells
22%
CD30
21%
Lymphoma Patients
20%
B-cell Lymphoma 2 (Bcl-2)
20%
De Novo Diffuse Large B-cell Lymphoma
19%
Mitogen-activated Protein Kinase
19%
Multiple Myeloma
18%
Tumor Cells
18%
Aptamer Probe
17%
Flow Cytometry
17%
Anaplastic Large Cell Lymphoma
17%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
17%
DNA Aptamer
16%
Interleukin-2
16%
B-cell Lymphoma
15%
Monoclonal Antibody
15%
Myeloma
15%
Tumor
15%
Tumor Protein p53 (TP53)
15%
Gene Expression Profiling
14%
Activated B Cells
14%
Myelodysplastic Syndrome
13%
Cancer Cells
12%
High Affinity
12%
Doxorubicin
12%
Germinal Center B Cells
12%
Aptamer Technology
11%
Flow Cytometry Data
10%
Immunohistochemistry
10%
Prognostic Significance
10%
Overexpression
10%
In Cancer
9%
Tumor Suppressor Activity
9%
Targeted Therapy
9%
Prognostic Impact
9%
Mitogen-activated Protein Kinase-activated Protein Kinase 2
9%
Nanomedicine
9%
Poor Prognosis
8%
Triple-negative Breast Cancer
8%
5-hydroxymethylcytosine (5hmC)
8%
Human Mesenchymal Stem Cells (hMSCs)
8%
Cell-free DNA (cfDNA)
8%
Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
71%
Aptamer
37%
B Cell
23%
B-Cell Lymphoma
21%
Rituximab
20%
CHOP
19%
Acute Myeloid Leukemia
18%
Neoplasm
17%
Gene Expression Profiling
17%
Flow Cytometry
16%
Lymphoma Cell
14%
Protein P53
14%
Myeloma Cell
13%
Epstein Barr Virus
13%
Immunohistochemistry
13%
Multiple Myeloma
12%
Doxorubicin
12%
T Cell
11%
Cancer Cell
11%
Oligonucleotide
11%
Monoclonal Antibody
10%
Germinal Center B-Cell Like Diffuse Large B-Cell Lymphoma
10%
Anaplastic Large Cell Lymphoma
9%
In Vitro
9%
Diseases
8%
Metastatic Carcinoma
8%
Receptor
7%
Specific Tumor
7%
Myelodysplastic Syndrome
7%
Tumor
7%
Cancer
7%
Leukemia
7%
Myeloproliferative Disorder
6%
Gene Mutation
6%
Overall Survival
6%
T Lymphocyte Receptor
6%
Triple Negative Breast Cancer
6%
Gene Expression
6%
Mitogen Activated Protein Kinase P38
6%
Cell Survival
6%
Tumor Cell
6%
Anaplastic Lymphoma Kinase
6%
5 Hydroxymethylcytosine
5%
Immunoglobulin
5%
Hodgkin's Lymphoma
5%
Cell-Free DNA
5%
Lymphoproliferative Disease
5%
CAR T-cell therapy
5%
Prevalence
5%
Leukemia Cell
5%
Biochemistry, Genetics and Molecular Biology
B Cell
60%
Aptamer
60%
Cancer Cell
20%
extracellular signal regulated kinase
20%
Myeloid
17%
Protein Kinase
15%
Rituximab
15%
Anaplastic Lymphoma Kinase
13%
CD30
13%
Doxorubicin
12%
Phosphotransferase
12%
Kinase
12%
Interleukin 2
11%
Genetics
11%
Gene Expression
10%
Gene Expression Profiling
10%
P53
9%
P38 Mitogen-Activated Protein Kinases
9%
Oligonucleotide
9%
Gene Mutation
8%
Programmed Cell Death
7%
T Cell
7%
Carcinogenesis
6%
RNA
6%
Gene Therapy
6%
Tumor Suppressor Protein
6%
Tumor Necrosis Factor
6%
Response Element
6%
Cyclic Adenosine Monophosphate
6%
Phosphoprotein
5%
Proteasome Inhibitor
5%
Side Population
5%
Ischemic Preconditioning
5%
Intravenous Immunoglobulin
5%
Tyrosine Kinase
5%
Receptor Tyrosine Kinase
5%
Genotyping
5%
N-Terminus
5%
Wild Type
5%
Flow Cytometry
5%
Peptide Sequence
5%
